Xeris Biopharma Holdings (XERS) Gross Profit (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly Gross Profit came in at $72.6 million in Q1 2026, up 41.18% YoY from $51.4 million in Q1 2025, and down 3.08% on a QoQ basis from $74.9 million in Q4 2025.
Xeris Biopharma Holdings (XERS) Gross Profit (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of Gross Profit data on file, last reported at $72.6 million in Q1 2026.
- Quarterly Gross Profit rose 41.18% year-over-year to $72.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270.4 million (up 47.81% YoY) and the FY2025 annual result came in at $249.3 million, up 49.95% from the prior year.
- Gross Profit retreated to $72.6 million in Q1 2026, from $74.9 million in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $74.9 million in Q4 2025 to a low of $15.8 million in Q1 2022.
- A 5-year average of $41.8 million and a median of $40.1 million in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2022 — Gross Profit soared 271.1% — and 2024, when it advanced 1.39%.
- Tracing XERS's Gross Profit over 5 years: stood at $26.9 million in 2022, then surged by 37.12% to $36.8 million in 2023, then jumped by 37.48% to $50.6 million in 2024, then jumped by 47.88% to $74.9 million in 2025, then declined by 3.08% to $72.6 million in 2026.
- The last three Gross Profit figures came in at $72.6 million (Q1 2026), $74.9 million (Q4 2025), and $63.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 79.59 Mn |
| Jun 30, 2026 | 79.59 Mn |
| Mar 31, 2026 | 72.55 Mn |
| Mar 31, 2026 | 72.55 Mn |
| Dec 31, 2025 | 74.86 Mn |
| Dec 31, 2025 | 74.86 Mn |
| Sep 30, 2025 | 63.38 Mn |
| Sep 30, 2025 | 63.38 Mn |
| Jun 30, 2025 | 59.64 Mn |
| Jun 30, 2025 | 59.64 Mn |
| Mar 31, 2025 | 51.39 Mn |
| Mar 31, 2025 | 51.39 Mn |
| Dec 31, 2024 | 50.62 Mn |
| Dec 31, 2024 | 50.62 Mn |
| Sep 30, 2024 | 40.68 Mn |
| Sep 30, 2024 | 40.68 Mn |
| Jun 30, 2024 | 40.28 Mn |
| Jun 30, 2024 | 40.28 Mn |
| Mar 31, 2024 | 34.67 Mn |
| Mar 31, 2024 | 34.67 Mn |